TABLE 4.
Covariate | Comparison | RH | 95% CI | P-value |
---|---|---|---|---|
Gender | Male vs. female | 0.60 | (0.43, 0.83) | 0.002 |
DF508 alleles | 1 or 2 vs. 0 | 1.54 | (0.98, 2.41) | 0.06 |
Culture history | ||||
S. aureus | Ever vs. never + | 0.38 | (0.25, 0.58) | <0.0001 |
S. aureus | Recent + vs. – | 0.23 | (0.17, 0.32) | <0.0001 |
BCC | Ever vs. never + | 1.32 | (0.61, 2.86) | 0.48 |
BCC | Recent + vs. – | 0.64 | (0.16, 2.63) | 0.54 |
S. maltophilia | Ever vs. never + | 1.58 | (0.97, 2.57) | 0.07 |
S altophilia | Recent + vs. — | 1.24 | (0.44, 3.51) | 0.69 |
Lung function | ||||
FEV1 % | 10% points ↓ | 1.20 | (1.11, 1.30) | <0.0001 |
FEV1 liters | 1 L ↓ | 1.75 | (1.32, 2.30) | <0.0001 |
FVC % | 10% points | 1.19 | (1.09, 1.30) | 0.0001 |
FVC liters | ↓ 1 L ↓ | 1.56 | (1.22, 2.01) | 0.0004 |
FEF25–75 % | 10% points | 1.12 | (1.05, 1.18) | 0.0002 |
FEF25–75 liters | ↓ 1 L ↓ | 1.40 | (1.16, 1.70) | 0.0005 |
Blood counts | ||||
WBC count | Twofold ↑ | 1.20 | (0.85, 1.68) | 0.30 |
Lymphocyte count | Twofold ↑ | 1.13 | (0.83, 1.55) | 0.43 |
Lymphocyte % | 10% points ↑ | 0.95 | (0.80, 1.13) | 0.55 |
Neutrophil count | Twofold ↑ | 1.26 | (0.97, 1.63) | 0.09 |
Neutrophil % | 10% points ↑ | 1.05 | (0.90, 1.22) | 0.57 |
Eosinophil count | Twofold ↑ | 1.00 | (0.86, 1.16) | 0.99 |
Eosinophil % | 1% point ↑ | 1.00 | (0.92, 1.09) | 0.95 |
Other markers | ||||
AAT | Twofold ↑ | 1.65 | (0.98, 2.77) | 0.06 |
Albumin | 1 g/dl ↑ | 0.77 | (0.51, 1.17) | 0.22 |
CRP | Twofold ↑ | 1.01 | (0.95, 1.08) | 0.70 |
Total protein | 1 g/dl ↑ | 0.81 | (0.63, 1.03) | 0.09 |
IgA | Twofold ↑ | 1.05 | (0.89, 1.25) | 0.55 |
IgG | Twofold ↑ | 1.10 | (0.76, 1.59) | 0.62 |
IgM | Twofold ↑ | 1.04 | (0.84, 1.31) | 0.70 |
Vitamin A | 1 mcg/dl ↑ | 0.98 | (0.97, 0.99) | 0.008 |
Vitamin E | 1 mg/L ↑ | 0.96 | (0.93, 1.00) | 0.08 |
RH, relative hazard; CI, confidence interval; BCC, Burkholderia cepacia complex; FEV1, forced expiratory volume in 1 sec; FVC, forced vital capacity; FEF25–75, mid peak flows.